These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22211010)

  • 1. Myeloperoxidase in chronic kidney disease.
    Madhusudhana Rao A; Anand U; Anand CV
    Indian J Clin Biochem; 2011 Jan; 26(1):28-31. PubMed ID: 22211010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
    Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respective role of uraemic toxins and myeloperoxidase in the uraemic state.
    Capeillère-Blandin C; Gausson V; Nguyen AT; Descamps-Latscha B; Drüeke T; Witko-Sarsat V
    Nephrol Dial Transplant; 2006 Jun; 21(6):1555-63. PubMed ID: 16476719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.
    Zeng L; Mathew AV; Byun J; Atkins KB; Brosius FC; Pennathur S
    J Biol Chem; 2018 May; 293(19):7238-7249. PubMed ID: 29581235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Myeloperoxidase, C-reactive Protein and α1-acid Glycoprotein: Insights about Cardiovascular Risk in End-stage Renal Disease.
    Rickli C; Borato DCK; Silva AJME; Schuinski AFM; Vilela GHF; Vellosa JCR
    Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):731-736. PubMed ID: 31049900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Hemodialysis on Plasma Myeloperoxidase Activity in End Stage Renal Disease Patients.
    Rao AM; Apoorva R; Anand U; Anand CV; Venu G
    Indian J Clin Biochem; 2012 Jul; 27(3):253-8. PubMed ID: 26405383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYELOPEROXIDASE AND COENZYME Q10 MODULATED IN THE CHRONIC KIDNEY DISEASE PATIENTS.
    Aziz H; Hussein A; Zakari M
    Georgian Med News; 2023 Nov; (344):124-128. PubMed ID: 38236112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of HDL Particles in Children with End-stage Renal Disease.
    Stefanović A; Ristovski-Kornic D; Kotur-Stevuljević J; Spasojević-Kalimanovska V; Vekić J; Miljković M; Paripović D; Peco-Antic A; Jelić-Ivanović Z; Zeljković A
    J Med Biochem; 2017 Oct; 36(4):358-365. PubMed ID: 30581333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.
    Hu X; Shen C; Meng T; Ooi JD; Eggenhuizen PJ; Zhou YO; Luo H; Chen JB; Lin W; Gong Y; Xiong Q; Xu J; Liu N; Xiao X; Tang R; Zhong Y
    Front Immunol; 2022; 13():991469. PubMed ID: 36389826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis.
    Mathew AV; Zeng L; Atkins KB; Sadri KN; Byun J; Fujiwara H; Reddy P; Pennathur S
    J Biol Chem; 2021; 296():100120. PubMed ID: 33234591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.
    Snauwaert E; Van Biesen W; Raes A; Holvoet E; Glorieux G; Van Hoeck K; Van Dyck M; Godefroid N; Vanholder R; Roels S; Walle JV; Eloot S
    Pediatr Nephrol; 2018 Feb; 33(2):315-323. PubMed ID: 28939943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
    Kitabayashi C; Naruko T; Sugioka K; Yunoki K; Nakagawa M; Inaba M; Ohsawa M; Konishi Y; Imanishi M; Inoue T; Itabe H; Yoshiyama M; Haze K; Becker AE; Ueda M
    Hemodial Int; 2013 Oct; 17(4):557-67. PubMed ID: 23627905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Role of Myeloperoxidase in the Prognosis of Nephrotic Syndrome Patients Before and After Steroid Therapy.
    Souparnika S; D'Souza B; D'Souza V; Kumar S; Manjrekar P; Bairy M; Parthasarathy R; Kosuru S
    J Clin Diagn Res; 2015 Jul; 9(7):BC01-4. PubMed ID: 26393116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.
    Buraczynska K; Koziol-Montewka M; Majdan M; Tokarz A; Ksiazek A
    Ren Fail; 2004 Nov; 26(6):633-9. PubMed ID: 15600254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase deficiency ameliorates progression of chronic kidney disease in mice.
    Lehners A; Lange S; Niemann G; Rosendahl A; Meyer-Schwesinger C; Oh J; Stahl R; Ehmke H; Benndorf R; Klinke A; Baldus S; Wenzel UO
    Am J Physiol Renal Physiol; 2014 Aug; 307(4):F407-17. PubMed ID: 24990898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Biomarkers of Oxidative Stress and Inflammation with Cardiac Necrosis and Heart Failure in Non-ST Segment Elevation Myocardial Infarction Patients and Various Degrees of Kidney Function.
    Roumeliotis S; Veljkovic A; Georgianos PI; Lazarevic G; Perisic Z; Hadzi-Djokic J; Liakopoulos V; Kocic G
    Oxid Med Cell Longev; 2021; 2021():3090120. PubMed ID: 34760045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of plasma myeloperoxidase in ESRD patients.
    Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
    Am J Kidney Dis; 2010 Nov; 56(5):937-46. PubMed ID: 20638167
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.